D-Wave, Quantum

D-Wave Quantum: Two Target Cuts, a Securities Suit and a November 10 Earnings Date Frame the Real Test

Published on 11/05/2026 at 16:50 | Editorial boerse-global.de
Wedbush and B. Riley lowered D-Wave price targets while keeping buy ratings; a class action surfaced and Q3 results are due November 10, 2026.
D-Wave Quantum Illustration mit AI erstellt.

D-Wave Quantum’s stock slid 15% in a single session, and the temptation is to pin the move on a single headline. The more useful reading sits elsewhere: two analysts trimmed their price targets while keeping their buy ratings, a securities class action surfaced, and the company has now fixed a date — November 10, 2026 — when business figures can take over the conversation from technical bulletins.

Wedbush cut its target to $30 from $37, according to media reports, while leaving its “Outperform” rating in place. That combination carries a specific message. It is not a retreat from a positive view of the company, but neither is it an unchanged view of what the shares are worth. B. Riley had done much the same on Monday: analyst Craig Ellis lowered his target to $27 from $40 and kept his buy call, citing weakness across quantum-computing and AI stocks.

A Warning Against the Comfortable Reading

Both moves point the same way — optimistic recommendations paired with lower price objectives. That undercuts the convenient assumption that bullish analyst coverage alone is enough to neutralize a falling share price. B. Riley’s rationale also sketches a strained sector backdrop, though it does not by itself explain every subsequent swing in D-Wave’s equity.

The distinction matters for anyone weighing the stock. Looking only at the reaffirmed rating ignores the reduced target; reading the cut as a wholesale negative verdict overshoots. The truth sits between the two: conviction on the business, less conviction on the valuation it can command.

Should investors sell immediately? Or is it worth buying D-Wave Quantum?

Technical Progress Is Not a Valuation Answer

D-Wave reported improvements to its Stride hybrid solver. By the company’s own account, the revised version produced better solutions within 15 seconds in comparative tests than the previous version managed in 120 seconds. Separately, the company launched a three-course learning path called “Applied Quantum Optimization,” aimed at the same underlying task — making quantum optimization easier for enterprises to adopt.

That is concrete technical progress by the measure of those tests, and the curriculum addresses a real gap: a tool has to work, but customers also need to understand where and how to deploy it. Neither development, however, automatically rebuts the lower targets. A product’s capability and a company’s appropriate valuation are separate questions, and that separation is precisely what the analyst actions bring into focus.

The same logic applies to the letter of intent signed roughly a week ago with LG CNS, intended to advance the adoption of quantum optimization among enterprises in South Korea and international markets. Its non-binding character is the key detail: the agreement describes a shared direction, not committed revenue.

Legal Risk Enters the Ledger

Bronstein, Gewirtz & Grossman announced a securities class action against D-Wave and certain executives. According to the firm, the suit was filed on October 15 and concerns the period from February 26 to August 25. A filing is not proof that its allegations have merit, and it should not be treated as a settled financial charge — but it belongs in any risk assessment.

What November 10 Can Actually Settle

D-Wave has scheduled third-quarter 2026 results for release before the market opens on November 10, 2026. That date gives the discussion a chance to shift from laboratory benchmarks and training programs toward actual business numbers.

The investor question runs along a chain: from a better tool, through trained users, to paying demand. Keeping those stages apart means neither dismissing technical advances nor mistaking them for a commercial breakthrough. The positive ratings are a counterweight to skepticism, not a substitute for economic confirmation — and the lowered targets deserve at least as much attention as the ratings that were kept.

Ad

D-Wave Quantum Stock: New Analysis - 5 November

Fresh D-Wave Quantum information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated D-Wave Quantum analysis...

Disclaimer...
en | US26740W1099 | D-WAVE | boerse | 70465032 |